KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Change in Acquisitions & Divestments: 2009-2025

Historic Change in Acquisitions & Divestments for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Sep 2025 value amounting to $98.8 million.

  • Biomarin Pharmaceutical's Change in Acquisitions & Divestments fell 38.55% to $98.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $449.1 million, marking a year-over-year decrease of 24.09%. This contributed to the annual value of $633.0 million for FY2024, which is 26.81% down from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Change in Acquisitions & Divestments of $98.8 million as of Q3 2025, which was down 16.22% from $117.9 million recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Change in Acquisitions & Divestments registered a high of $275.9 million during Q2 2023, and its lowest value of $77.8 million during Q1 2025.
  • Over the past 3 years, Biomarin Pharmaceutical's median Change in Acquisitions & Divestments value was $154.6 million (recorded in 2024), while the average stood at $162.9 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first soared by 105.53% in 2021, then slumped by 40.85% in 2025.
  • Quarterly analysis of 5 years shows Biomarin Pharmaceutical's Change in Acquisitions & Divestments stood at $188.9 million in 2021, then decreased by 24.45% to $142.8 million in 2022, then decreased by 20.71% to $113.2 million in 2023, then skyrocketed by 36.57% to $154.6 million in 2024, then crashed by 38.55% to $98.8 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $98.8 million for Q3 2025, versus $117.9 million for Q2 2025 and $77.8 million for Q1 2025.